Vanguard Group Inc Biote Corp. Transaction History
Vanguard Group Inc
- $5.37 Trillion
- Q1 2025
A detailed history of Vanguard Group Inc transactions in Biote Corp. stock. As of the latest transaction made, Vanguard Group Inc holds 1,412,165 shares of BTMD stock, worth $4.89 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,412,165
Previous 1,430,110
1.25%
Holding current value
$4.89 Million
Previous $8.95 Million
47.48%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding BTMD
# of Institutions
90Shares Held
17MCall Options Held
0Put Options Held
0-
325 Capital LLC New York, NY4.55MShares$15.7 Million7.37% of portfolio
-
Bandera Partners LLC New York, NY2.44MShares$8.43 Million2.95% of portfolio
-
Black Rock Inc. New York, NY1.61MShares$5.55 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA701KShares$2.43 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX652KShares$2.26 Million0.0% of portfolio
About biote Corp.
- Ticker BTMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 7,574,270
- Market Cap $26.2M
- Description
- biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...